IRIS
MARAOLO, ALBERTO ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.067
EU - Europa 1.940
NA - Nord America 1.744
SA - Sud America 434
AF - Africa 66
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.258
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.660
US - Stati Uniti d'America 1.614
RU - Federazione Russa 1.096
CN - Cina 771
BR - Brasile 355
IT - Italia 314
HK - Hong Kong 285
VN - Vietnam 163
DE - Germania 123
NL - Olanda 102
CA - Canada 72
FI - Finlandia 63
KR - Corea 63
GB - Regno Unito 61
MX - Messico 37
IE - Irlanda 36
AR - Argentina 35
IN - India 29
PL - Polonia 26
FR - Francia 21
ZA - Sudafrica 21
AT - Austria 20
ID - Indonesia 15
EC - Ecuador 14
JP - Giappone 14
SE - Svezia 14
MA - Marocco 12
BD - Bangladesh 11
ES - Italia 11
LT - Lituania 11
TR - Turchia 11
CI - Costa d'Avorio 9
IQ - Iraq 9
UA - Ucraina 8
BE - Belgio 7
CO - Colombia 6
SA - Arabia Saudita 6
TN - Tunisia 6
CL - Cile 5
JM - Giamaica 5
PY - Paraguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
BG - Bulgaria 4
PE - Perù 4
RS - Serbia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CH - Svizzera 3
DZ - Algeria 3
EG - Egitto 3
OM - Oman 3
PH - Filippine 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RO - Romania 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AL - Albania 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
HT - Haiti 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LV - Lettonia 1
ME - Montenegro 1
MY - Malesia 1
NA - Namibia 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
PW - Palau 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.256
Salva come PNG Salva come JPEG
Città #
Singapore 773
Hefei 324
Hong Kong 283
Moscow 261
Beijing 191
Ashburn 151
Chandler 146
Santa Clara 110
Los Angeles 104
Naples 71
Amsterdam 65
Ho Chi Minh City 62
Seoul 62
Millbury 58
Munich 46
New York 43
Redondo Beach 42
São Paulo 39
Nuremberg 35
Ottawa 34
Des Moines 33
Boston 32
Buffalo 32
The Dalles 32
Hanoi 30
Napoli 28
Dallas 26
Lawrence 24
Rome 24
Seattle 24
Lappeenranta 23
Princeton 22
Montreal 20
Warsaw 19
Turku 18
Mexico City 17
Nanjing 17
Johannesburg 14
Wilmington 14
Atlanta 13
Boardman 13
Manchester 13
Poplar 13
Belo Horizonte 12
Frankfurt am Main 12
Stockholm 12
Brooklyn 11
Helsinki 11
Milan 11
Rio de Janeiro 11
Tokyo 11
Da Nang 10
Orem 10
Querétaro 10
Denver 9
Vienna 9
Chicago 8
Dublin 8
Jiaxing 8
Kochi 8
Nanchang 8
Toronto 8
Haiphong 7
Mugnano di Napoli 7
Porto Alegre 7
Rochdale 7
San Francisco 7
Cardito 6
Falkenstein 6
Fisciano 6
Florence 6
Guangzhou 6
Hebei 6
Bengaluru 5
Brasília 5
Brussels 5
Changsha 5
Chennai 5
Curitiba 5
Elk Grove Village 5
Guarulhos 5
Ha Long 5
Houston 5
Itajaí 5
Phoenix 5
Salvador 5
Tashkent 5
Ankara 4
Biên Hòa 4
Bologna 4
Casablanca 4
Caserta 4
Fortaleza 4
Hải Dương 4
Jakarta 4
Japeri 4
London 4
Manaus 4
Richmond 4
Riyadh 4
Totale 3.781
Salva come PNG Salva come JPEG
Nome #
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 133
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 133
Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case–Control Study (SAVALO Study) 127
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 127
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 122
Secondary syphilis mimicking malignancy: A case report and review of literature 121
Diabetes Mellitus Type 1, Latent Autoimmune Diabetes of Adults and Hepatitis C Virus: What we Know and what we Need to Know 115
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 109
Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis 109
Appropriateness of antibiotic prescription for targeted therapy of infections caused by multidrug-resistant bacteria: Assessment of the most common improper uses in a tertiary hospital in Southern Italy 108
Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case–control study (SAVALO Study)(BMC Infect Dis., (2024), 24, 1434, 10.1186/s12879-024-10303-5) 106
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 105
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 105
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 103
Risk of professional accidental exposure to biological agents in health care workers: a retrospective analysis carried out in a southern Italian tertiary hospital 102
Beclabuvir for the treatment of hepatitis C 102
Efficacy of ultra-short single agent regimen antibiotic chemo-prophylaxis in reducing the risk of meningitis in patients undergoing endoscopic endonasal transsphenoidal surgery 102
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 102
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 102
Postvaccination SARS-CoV-2 Infections among Healthcare Professionals: A Real World Evidence Study 100
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 100
Current evidence on the management of hepatitis B in pregnancy 99
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 98
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 98
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 97
Is anticoagulation with novel oral anticoagulants an effective treatment for tuberculosis patients not achieving a therapeutic range with vitamin k antagonists? A Systematic Review 97
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 94
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 92
Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy 91
Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review 91
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis 89
Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectives 88
Limiting the access to direct-acting antivirals against HCV: an ethical dilemma 86
Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet 86
The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies 86
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 84
Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry 84
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 84
Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused 83
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience 83
Covid-19: Time for post-exposure prophylaxis? 80
Daptomycin versus vancomycin for the treatment of methicillin-resistant staphylococcus aureus bloodstream infection with or without endocarditis: A systematic review and meta-analysis 79
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam? 79
Measles in pregnant women: A systematic review of clinical outcomes and a meta-analysis of antibodies seroprevalence 78
Human Campylobacter spp. infections in Italy 78
Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic Options 75
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network) 75
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 75
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE – a multi-centre experience in Italy 75
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion 73
Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with covid-19: A multicenter study 71
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 69
Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey 69
NS5B polymerase inhibitors in phase II clinical trials for HCV infection 69
Respiratory Intensive Care Unit management and efficacy during the COVID-19 outbreak in Naples, Italy 67
The revival of aztreonam in combination with avibactam against metallo-β-lactamase-producing gram-negatives: A systematic review of in vitro studies and clinical cases 67
A rare association of liver abscess and rhabdomyolysis induced by Klebsiella oxytoca 67
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry 65
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults 65
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients 62
Use of colistin in adult patients: A cross-sectional study 60
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis 60
A subanalysis of Clostridium perfringens bloodstream infections from a 5-year retrospective nationwide survey (ITANAEROBY) 60
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications 60
Re: Persistent COVID-19 in immunocompromised patients-Israeli Society of Infectious Diseases consensus statement on diagnosis and management by Meijer et al 58
Liver fungal infections: An overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies 57
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience 57
Colistin plus meropenem versus colistin alone for invasive infections caused by carbapenem-resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian meta-analysis 56
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs 56
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 55
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa 55
Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials 54
Short Course Antibiotic Therapy for Catheter-Related Septic Thrombosis: “Caveat Emptor!”: Duration of Therapy Should Not Be Set a Priori 53
Predisposing factor, impactful adjunctive treatment or unfavorable prognostic marker: a meta-analysis on the elusive role of dexamethasone for Listeria monocytogenes meningitis. 52
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship 52
Editorial for the Special Issue: “The Issue of Multidrug-Resistant Pathogens in Nosocomial Infections” 51
Personal life and working conditions of trainees and young specialists in clinical microbiology and infectious diseases in Europe: a questionnaire survey 50
Fosfomycin as partner drug for systemic infection management. a systematic review of its synergistic properties from in vitro and in vivo studies 50
Management of chickenpox in pregnant women: an Italian perspective 49
Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study 48
Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections 48
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 47
Letter: The potential success of long-term therapy of chronic delta hepatitis with peginterferon alfa 47
Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies 43
Response to: ‘Letter to the Editor: “Management of multidrug-resistant Pseudomonas aeruginosa in the Intensive Care Unit: state of the art”’ 43
Prevention of hepatitis B virus infection: from the past to the future 43
Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies 42
Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case–control–control study 40
Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study 39
Editorial: Viral Infections in the Intensive Care Unit 37
Changes in the relative prevalence of candidaemia due to non-albicans Candida species in adult in-patients: A systematic review, meta-analysis and meta-regression 37
What do we know About the Usefulness of 18F-FDG PET-CT for the Management of Invasive Fungal Infection? An International Survey 36
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 35
Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis 35
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review 34
Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis 34
Kaposi sarcoma and vertebral involvement in people with HIV: a case report and systematic literature review 33
Which trials do we need? Fidaxomicin plus either intravenous metronidazole or tigecycline versus vancomycin plus either intravenous metronidazole or tigecycline for fulminant Clostridioides difficile infection 31
Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey 30
Editorial for the Special Issue: “Current and Novel Antimicrobial Strategies for Bacterial and Fungal Infections by Resistant Organisms” 26
Totale 7.334
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.033
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 6 9 0 3 6 0 0
2021/2022251 3 0 1 1 0 4 1 9 33 12 71 116
2022/2023382 48 31 19 24 31 36 1 39 54 64 26 9
2023/2024272 13 50 38 13 24 32 7 24 2 2 43 24
2024/20252.642 62 59 64 105 97 132 319 172 178 262 916 276
2025/20263.532 581 607 614 650 913 167 0 0 0 0 0 0
Totale 7.429